Common Contracts

4 similar Securities Purchase Agreement contracts by AIM ImmunoTech Inc., InspireMD, Inc., Roadzen Inc., Tharimmune, Inc.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 31st, 2025 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 28, 2025, between AIM ImmunoTech Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 31st, 2025 • InspireMD, Inc. • Surgical & medical instruments & apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 30, 2025, between InspireMD, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 31st, 2025 • Tharimmune, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 25, 2025, between Tharimmune, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 31st, 2025 • Roadzen Inc. • Insurance agents, brokers & service • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of July 27, 2025, between Roadzen Inc., a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).